Features

Before there were MRI machines or CT scans—never mind the possibility of using AI to unlock the mysteries of the human brain—there was Civitan International.

When it comes to cervical cancer, Alabama has one of the highest rates of new cases and mortality. A dire situation to be sure, but there is a silver lining: Alabama also leads the country in the effort to eliminate cervical cancer as a public health threat.

Academic medical centers (AMCs) are among the United States’ most active hives of biomedical innovation thanks to their often robust research enterprises. Increasingly, AMCs like the Heersink School of Medicine play a central role in another realm of innovation: the biomedical/biotech start-up space.

As chair of the UAB Department of Psychiatry and Behavioral Neurobiology, Adrienne Lahti, M.D., has a unique perspective on the mental health care landscape in Alabama. “Alabama ranks very low in mental health care,” she said. “In metrics comparing different states’ mental health statistics and access to care, Alabama is usually at 47, 48, 49. The demand is huge.”

As our society evolves so, too, do the health challenges we face. UAB Medicine is at the forefront of addressing emerging and evolving health issues with the introduction of new clinics and programs designed to meet the dynamic needs of patients at every stage of life. Among these are the UAB Comprehensive Smell and Taste Clinic, which responds to the increased prevalence of smell and taste disorders following the COVID-19 pandemic, providing specialized care and innovative treatment options.

In the early 1980s, a hit TV show introduced many Americans to artificial intelligence (AI). While Michael Knight, famously portrayed by David Hasselhoff, was technically the main character of “Knight Rider,” it was KITT, a black 1982 Pontiac Trans Am with the power to think and talk, that spurred fans of the show to tune in week after week.

“Alabama is a hotbed for fungal diseases,” said Peter Pappas, M.D., professor in the Division of Infectious Diseases in the Heersink School of Medicine. “We see as much or more in the way of fungal infections as anyone in the country.” Pappas is a leader of the Mycoses Study Group, a world-renowned, UAB administered group of experts who focus on understanding and treating invasive fungal infections and have led most of the clinical trials for FDA-approved antifungal treatments. (Mycology is the study of fungi; mycoses are invasive fungal infections.)

The summer of 2024 marked a transformational turning point for health care in Alabama with two important developments. These advances promise to not only improve access to care for people in the Birmingham area and across the state, but also to advance the UAB Health System’s mission to provide life-changing care to all it serves.